DexCom Inc (DXCM): Market Cap to Revenue

Symbol and logo of brand DexCom Inc (DXCM)

DexCom, Inc. (DXCM) has transformed diabetes therapy by integrating its sensors with external pumps. Global demand ensures a steady flow of funds for R&D development. The current P/S multiple, with a present value of 5.90, illustrates the resilience of the capitalization relative to revenue growth rates. High margins are sustained through automated production and the regular replacement of sensors by patients.

DXCM DexCom Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Dexcom Corp (DXCM)

- share price and consensus valuation forecast:
Price Performance Chart dexcom.com|DXCM - Price Target Chart
- stock exchange capitalization data:
Market Valuation Dexcom Corp|DXCM - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Dexcom|DXCM - Book Capitalization|Capitalization to Book Value Ratio dexcom.com|DXCM - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient DexCom, Inc.|DXCM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Dexcom CGM|DXCM - Company Aggregate Debts|Debts to Book Capitalization Dexcom Corp|DXCM - Company Long-Term Debt|Company Short-Term Debt Dexcom|Intermediate Coverage Ratio dexcom.com
- earnings and multiples data:
DXCM - Net Profit|Expected Net Profit DexCom, Inc.|DXCM - Price to Earnings Ratio|Forward Price to Earnings Multiple DexCom Inc|DXCM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Dexcom Corp|DXCM - Operating profit EBITDA|Net earnings per share for the last four quarters Dexcom|DXCM - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months dexcom.com|DXCM - Earnings per share growth in current year|Expected earnings per share growth for next year DexCom, Inc.
- issuer revenue and sales details:
DXCM - Revenue and Sales Volume|Company Expected Sales Volume dexcom.com|DXCM - Price-to-Revenue Ratio|Market Cap to Projected Revenue Dexcom Corp
General company analysis:DXCM dexcom.com
Core merchandise of DexCom, Inc.

DexCom, Inc. (DXCM) represents a non-cyclical business in the critical medical equipment sector, which ensures high revenue resilience against macroeconomic shocks. An analysis of historical P/S allows for the valuation of each unit of sales and identifies a defensive discount when quotes deviate from long-term averages, confirming the company's fundamental reliability through the stability of its cash flows.

Competitors of DexCom, Inc.

PEN (penumbrainc.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Novanta NOVT|HAE - Market Cap to Revenue|Inspire Sleep - P/S Multiple|Price to Sales Procept|CNMD: P/S Multiple|Market Cap to Revenue Ratio PLSE|INMD (InMode) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|Market Cap to Revenue Ratio SSKN|GCTK (GlucoTrack, Inc.) - P/S Multiple|Price to Sales nanovibronix.com NAOV|Market Cap to Revenue VERO (Venus Concept Corp)|Nuwellis Corp - Market Cap to Revenue Ratio|P/S Multiple AEMD (Aethlon Medical)|ASXC - Market Cap to Revenue|AVGR - Price-to-Revenue Ratio|Price to Sales BioSig|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Market Cap to Revenue Know Labs Corporation|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|Price-to-Revenue Coefficient Silk Road Medical, Inc.